Epidemiological clinical characterization of patients with advanced chronic kidney disease

Authors

  • Lexis Caridad Ramírez Felipe Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Yandi Noel Martínez Cuéllar Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Yuniel González Cárdenas Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Yoel Santos Treto Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Keywords:

renal insufficiency, chronic, epidemiology

Abstract

Chronic kidney disease is considered as one of the major epidemics of the XXI century and provides a significant burden of morbidity and mortality in the world; it is important to identify and modify the factors of risk that influence its progression. In order to characterize the advanced chronic kidney disease and the evolution of patients in Progression consultation, it was performed a cross-sectional, observational and descriptive research with quantitative approach in the “Arnaldo Milian Castro” Hospital between September 2011 and September 2014. The study population consisted of all patients with advanced chronic kidney disease who were attended in the consultation, intentionally a sample of 110 patients was selected; they were taken into account criteria of inclusion and exclusion. Most of the patients were in stage IV of the disease and, in general, they suffered for less than six years. The hypertension, the hyperlipidemia and the proteinuria were the main factors of progression; it was associated the cardiovascular morbidity, which increased with age.

Downloads

Download data is not yet available.

Author Biographies

Lexis Caridad Ramírez Felipe, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral y en Nefrología. Máster en Medicina Bioenergética y Natural. Profesora Asistente de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Yandi Noel Martínez Cuéllar, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral y en Nefrología

Yuniel González Cárdenas, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral y en Nefrología. Profesor Instructor de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Yoel Santos Treto, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral y en Nefrología. Máster en Educación Médica. Profesor Asistente de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

References

1. Martínez-Castelao A, Górriz JL, Bover J, Segura-de la Morena J, Cebollada J, Escalada J, et al. Documento de consenso para la detección y manejo de la enfermedad renal crónica. Nefrología [Internet]. 2014 [citado 20 Jul 2014];34(2):243-262. Disponible en: http://scielo.isciii.es/pdf/nefrologia/v34n2/documento_consenso.pdf

2. Uchikawa T, Shimano M, Inden Y, Murohara T. Serum albumin levels predict clinical outcomes in chronic kidney disease (CKD) patients undergoing cardiac resynchronization therapy. Intern Med [Internet]. 2014 [citado 20 Jul 2015];53(6):555-61. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24633024

3. Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario estadístico de salud 2013 [Internet]. 2014 [citado 22 Jul 2015]. Disponible en: http://files.sld.cu/dne/files/2014/05/anuario-2013-esp-e.pdf

4. Campbell KH, Smith SG, Hemmerich J, Stankus N, Fox C, Mold JW, et al. Patient and provider determinants of nephrology referral in older adults with severe chronic kidney disease: a survey of provider decision-making. BMC Nephrology [Internet]. 2011 [citado 20 Jul 2015];12:47. Disponible en: http://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-12-47

5. Cusumano AM. Enfermedad renal crónica: necesidad de implementar programas para su detección precoz y prevención de su progresión. Acta Cient Estud. 2007;5(4):139-46.

6. Martínez-Ocaña JC. Gestión de la enfermedad renal crónica avanzada. Diálisis y Trasplante [Internet]. 2011 [citado 22 Mar 2014];32(4): [aprox. 5 p.]. Disponible en: http://www.elsevier.es/es-revista-dialisis-trasplante-275-articulo-gestion-enfermedad-renal-cronica-avanzada-90040567

7. García E, Merino JL, Bueno B, Romero A, Amézquita Y, Gómez A, et al. Eficacia y optimización de tiempos de administración de carboximaltosa férrica en la consulta de enfermedad renal crónica avanzada para el tratamiento de la anemia. Diálisis y Trasplante [Internet]. 2015 Jul-Dic [citado 10 Feb 2016];36(2):[aprox. 3 p.]. Disponible en: http://www.elsevier.es/es-revista-dilisis-trasplante-275-articulo-p-align-left-eficacia-optimizacion-tiempos-90433829?referer=buscador

8. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA [Internet]. 2011 [citado 20 Abr 2014];305(15):1545-52. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21482744

9. Duran-Perez EG, Almeda-Valdes P, Cuevas-Ramos D, Campos-Barrera E, Muñoz-Hernandez L, Gomez-Perez FJ. Treatment of metabolic syndrome slows progression of diabetic nephropathy. Metab Syndr Relat Disord [Internet]. 2011 [citado 10 Nov 2014];9(6):483-9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21875335

10. Goicoechea M, De Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol [Internet]. 2010 [citado 10 Nov 2014];5(8):1388-93. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20538833

11. Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20(5):390-5 [Internet]. 2013 [citado 20 Jul 2014];20(5):390-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23978543

12. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis [Internet]. 2010 [citado 15 Jul 2014];55(4):660-70. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20138414

13. Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J [Internet]. 2011 [citado 20 Abr 2014];162(3):548-54. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21884875

14. Meijer E, Rook M, Tent H, Navis G, van der Jagt EJ, de Jong PE, et al. Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol [Internet]. 2010 [citado 20 Jul 2014];5(6):1091-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20413443

15. Neumann I, Grassi B. Análisis crítico de un artículo: La adición de antagonistas del receptor de angiotensina 2 al tratamiento con inhibidores de la enzima convertidora de angiotensina en pacientes con riesgo de enfermedad renal, aumenta la incidencia de falla renal y la necesidad de diálisis. Rev Méd Chile [Internet]. 2012 [citado 9 Feb 2015 Jul 20];140(1):117-120. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000100018&lng=es

16. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet [Internet]. 2013 [citado 20 Jul 2014]; 382(9889):339–352. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23727170

17. Wilfred DC, Mysorekar VV, Venkataramana RS, Eshwarappa M, Subramanyan R. Nondiabetic renal disease in type 2 diabetes mellitus patients: a clinicopathological study. J Lab Physicians [Internet]. 2013 [citado 2 Jul 2015];5(2):94-99. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968638/

18. Pugliese G, Solini A, Bonora E, Orsi E, Zerbini G, Fondelli C, et al. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol [Internet]. 2014 [citado 23 Jun 2015];13:59. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24624891

19. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, et al. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med [Internet]. 2010 [citado 12 Nov 2014];363(12):1146-55. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20843249

20. Organización Panamericana de la Salud. Situación de salud en las Américas: Indicadores Básicos 2014 [Internet]. Washington, DC: OPS; 2015 [citado 8 Ene 2016]. Disponible en:

http://www.paho.org/hq/index.php?option=com_content&view=article&id=7170%3A2012-health-situation-americas-health-indicators-2014&catid=2394%3Arho-reports&Itemid=2395&lang=es

Downloads

Published

2016-07-01

How to Cite

1.
Ramírez Felipe LC, Martínez Cuéllar YN, González Cárdenas Y, Santos Treto Y. Epidemiological clinical characterization of patients with advanced chronic kidney disease. Acta Méd Centro [Internet]. 2016 Jul. 1 [cited 2025 Sep. 13];10(3):10-8. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/680

Issue

Vol. 10 No. 3 (2016): July-September

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).